<italic>Momordica charantia</italic> phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo.
MLA
Ahmadi Ghezeldasht, Sanaz, et al. “Momordica Charantia Phytoconstituents Can Inhibit Human T-Lymphotropic Virus Type-1 (HTLV-1) Infectivity in Vitro and in Vivo.” Journal of NeuroVirology, Aug. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1007/s13365-023-01160-0.
APA
Ahmadi Ghezeldasht, S., Bidkhori, H. R., Miri, R., Baghban, A., Mosavat, A., & Rezaee, S. A. (2023). Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo. Journal of NeuroVirology, 1–11. https://doi.org/10.1007/s13365-023-01160-0
Chicago
Ahmadi Ghezeldasht, Sanaz, Hamid Reza Bidkhori, Raheleh Miri, Arezoo Baghban, Arman Mosavat, and Seyed Abdolrahim Rezaee. 2023. “Momordica Charantia Phytoconstituents Can Inhibit Human T-Lymphotropic Virus Type-1 (HTLV-1) Infectivity in Vitro and in Vivo.” Journal of NeuroVirology, August, 1–11. doi:10.1007/s13365-023-01160-0.